Durability and safety of a novel salvage therapy in R5-tropic HIV-infected patients: Maraviroc, raltegravir, etravirine
Academic Article
Publication Date:
2011
Iris type:
1.1.2. Articolo in Rivista - Letter, Note
Keywords:
Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cyclohexanes; Female; HIV Infections; Humans; Male; Maraviroc; Middle Aged; Nitriles; Pyridazines; Pyrimidines; Pyrrolidinones; RNA, Viral; Raltegravir Potassium; Salvage Therapy; Treatment Outcome; Triazoles; Viral Load
List of contributors:
Nozza, S.; Galli, L.; Bigoloni, A.; Nicola, G.; Pogliaghi, M.; Cossarini, F.; Salpietro, S.; Galli, A.; Torre, L. D.; Tambussi, G.; Lazzarin, A.; Castagna, A.
Published in: